We are live on ! Find out more
EWM

Essex Woodlands Management Portfolio holdings

AUM $254M
1-Year Est. Return 4.59%
This Fund
S&P 500
This Quarter Est. Return
+17.89%
1 Year Est. Return
+4.59%
3 Year Est. Return
+54.96%
5 Year Est. Return
+25.37%
10 Year Est. Return
+254.56%
AUM
$431M
AUM Growth
-$26.3M
Cap. Flow
-$40.7M
Cap. Flow %
-9.44%
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
1
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
EYPT icon
EyePoint Inc
EYPT
+$33.1M

Top Sells

Rank Stock Value
1
ABMD
Abiomed Inc
ABMD
+$58.7M
2
RVNC
Revance Therapeutics, Inc.
RVNC
+$15M

Sector Composition

Rank Sector Weight
1 Healthcare 96.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXGN icon
1
Axogen
AXGN
$2.59B
$186M 43.3%
3,711,111
– –
RVNC
2
DELISTED
Revance Therapeutics, Inc.
RVNC
$91.7M 21.3%
3,342,047
-500,000
-13% -$15M
CORI
3
DELISTED
Corium International, Inc.
CORI
$74.9M 17.4%
9,353,304
– –
EYPT icon
4
EyePoint Inc
EYPT
$1.13B
$53M 12.3%
2,547,039
+1,686,407
+196% +$33.1M
ELGX
5
DELISTED
Endologix Inc
ELGX
$13.6M 3.16%
125,747
– –
MNOV icon
6
MediciNova
MNOV
$65M
$9.32M 2.16%
1,170,370
– –
GYRE icon
7
Gyre Therapeutics
GYRE
$749M
$933K 0.22%
10,483
– –
ACUR
8
DELISTED
Acura Pharmaceuticals
ACUR
$704K 0.16%
1,956,397
– –
ABMD
9
DELISTED
Abiomed Inc
ABMD
– –
-201,818
Closed -$58.7M

Similar funds

TSM
Two Star Manager Miami Beach, Florida $254M AUM 3.61% 1-Year Est. Return
LI
LHM Inc Sandy, Utah $254M AUM 13.16% 1-Year Est. Return
LIA
LifePlan Investment Advisors Raleigh, North Carolina $254M AUM 17.26% 1-Year Est. Return
IGM
Incline Global Management New York $255M AUM 7.23% 1-Year Est. Return
WWM
Westwood Wealth Management Los Angeles, California $255M AUM 54.97% 1-Year Est. Return
MWM
MorganRosel Wealth Management Highlands Ranch, Colorado $254M AUM 18.87% 1-Year Est. Return
LRIC
Long Road Investment Counsel Kalamazoo, Michigan $255M AUM 12.85% 1-Year Est. Return
CIM
Caldwell Investment Management Toronto, Ontario, Canada $255M AUM 36.87% 1-Year Est. Return

Essex Woodlands Management's Q2 2018 Portfolio in Review

As of Q2 2018, Essex Woodlands Management held 9 positions worth $431M, down 5.7% from $457M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Essex Woodlands Management withdrew a net $40.7M in Q2 2018, closing 1 position and reducing 1 holding. Its most notable exit was Abiomed Inc, an estimated $58.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, down from 97% a quarter earlier.

Against the trend, Essex Woodlands Management added an estimated $33.1M to EyePoint Inc.

  • Essex Woodlands Management added most to EyePoint Inc in Q2 2018, an estimated $33.1M increase.
  • Essex Woodlands Management's biggest Q2 2018 reduction was Revance Therapeutics, Inc., cutting an estimated $15M.
  • Essex Woodlands Management fully exited Abiomed Inc in Q2 2018, selling an estimated $58.7M.
  • Essex Woodlands Management's ten largest holdings make up 100% of its $431M portfolio in Q2 2018.
  • Essex Woodlands Management opened 0 new positions and closed 1 in Q2 2018.
  • Essex Woodlands Management's portfolio value fell 5.7% quarter-over-quarter to $431M.

Based on Essex Woodlands Management's 13F filing for Q2 2018, filed 14 Aug 2018.